The FEZ2 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population, derived from the Raji B lymphocyte cell line, designed for targeted disruption of the FEZ2 gene. This product provides a robust loss-of-function model to study FEZ2-mediated molecular interactions and signaling in a non-neuronal, immune-cell context. The polyclonal nature ensures a diverse pool of gene-disrupted alleles, suitable for reproducible functional analyses across multiple experimental formats.
The Raji cell line is a well-characterized lymphoblastoid line established from a Burkitt??s lymphoma patient, positive for Epstein-Barr virus (EBV) and expressing the B-cell marker CD19. Widely utilized in immunological and oncological research, its stable phenotype and robust growth facilitate consistent experimental outcomes. In this knockout setting, Raji cells offer a distinctive platform to investigate FEZ2, a gene classically linked to neuronal development, within B lymphocytes, potentially revealing uncharacterized roles in immune signaling.
FEZ2 (fasciculation and elongation protein zeta 2) functions as a scaffold protein integral to axonal outgrowth and fasciculation. It directly interacts with protein kinase C zeta (PKC??) and disrupted in schizophrenia 1 (DISC1), placing it centrally within the DISC1 interactome, a network associated with neuropsychiatric disorders. Regulated by neurotrophic factors and PKC?? activators, FEZ2 acts downstream of PKC?? to modulate actin cytoskeleton dynamics and neuronal differentiation markers. It forms complexes with FEZ1, PKC??, and DISC1, coordinately influencing intracellular signaling cascades. Knockout of FEZ2 is anticipated to disrupt these protein interactions and downstream cellular responses.
Although FEZ2 canonical functions are rooted in neuronal systems, its expression in Raji B cells implies broader physiological roles. This model enables dissection of FEZ2-dependent molecular pathways in an immune context, thereby furnishing a valuable tool to examine schizophrenia-associated protein interactions outside the nervous system. The EBV-positive B-cell background may also illuminate intersections between viral latency and FEZ2 signaling, and facilitate studies on how neuropsychiatric risk genes influence immune cell biology. Such insights are critical for understanding neuroimmune crosstalk in disease.
Researchers can employ the FEZ2 Knockout Raji Polyclonal Cells in co-immunoprecipitation assays to delineate protein interaction networks, or in Western blot and RT-qPCR experiments to validate expression changes in downstream targets such as cytoskeletal regulators. Functional assays including cell proliferation and apoptosis measurements can assess FEZ2??s impact on B-cell physiology. Immunofluorescence techniques can visualize alterations in actin organization. Furthermore, these cells serve as a model to study the PKC??-DISC1 signaling axis in immune contexts, relevant to schizophrenia and neuropsychiatric conditions. For further information, please contact Ascent Research.
